Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

Биологические маркеры тревожных расстройств, ОКР и ПТСР: консенсусное заключение. Часть II: нейрохимия, нейрофизиология и нейрокогнитивные функции
Naomi Anne Fineberg, Katharina Domschke, Peter Franz Riederer, David S. Baldwin, Eduard Maron, Dirk Wedekind, Andreas Ströhle, David Nutt, Stefano Pallanti, Samuel Robin Chamberlain, Yong‐Ku Kim, Stefano Pini, Edna Grünblatt, Matilde Maria Serena Vaghi, Adam Wichniak, Borwin Bandelow, Michel Bourin, Marek Jarema, Eunsoo Won, Marianna Abelli, Simon Davies, Peter Zwanzger, Blanca Miriam Bolea-Alamanac, Eduardo Cinosi, Vasileios Masdrakis, Olya Mikova, Florence Thibaut, Jade Woolley
2016-07-15

anxiety disordersheart rate variabilityneurochemical biomarkersobsessive-compulsive disorderposttraumatic stress disorder
Objective: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD).Methods: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network.Results: The present article (Part II) summarises findings on potential biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics.Conclusions: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.
1
Accumulated high-quality biomarker research is improving understanding of the neurobiological causes of anxiety disorders, OCD, and PTSD.
2
Neurophysiological and neurocognitive research has examined EEG, heart-rate variability, and cognitive characteristics as possible biomarkers for these disorders.
3
No currently identified biomarker is sufficiently specific and adequate to serve as a diagnostic tool.
4
Potential neurochemical markers include neurotransmitter systems, neuropeptides, the HPA axis, neurotrophic factors, immunological measures, and CO2 hypersensitivity.
5
The consensus statement reviews potential biomarkers for anxiety disorders, OCD, and PTSD across neurochemistry, neurophysiology, and neurocognition.

Anxiety disorders, obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD)

Potential biomarkers and their neurochemical, neurophysiological, and neurocognitive characteristics for these disorders

Publication Details
Publication Date
2016-07-15
Journal
Publisher
ISSN
Cited by
347
Access Type
Author Information
Authors
Naomi Anne Fineberg
Katharina Domschke
Peter Franz Riederer
David S. Baldwin
Eduard Maron
Dirk Wedekind
Andreas Ströhle
David Nutt
Stefano Pallanti
Samuel Robin Chamberlain
Yong‐Ku Kim
Stefano Pini
Edna Grünblatt
Matilde Maria Serena Vaghi
Adam Wichniak
Borwin Bandelow
Michel Bourin
Marek Jarema
Eunsoo Won
Marianna Abelli
Simon Davies
Peter Zwanzger
Blanca Miriam Bolea-Alamanac
Eduardo Cinosi
Vasileios Masdrakis
Olya Mikova
Florence Thibaut
Jade Woolley
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%